APAC (Dipeptide Peptidase- IV) DPP- IV Inhibitors Market, Market Segmented, by Drug Type (Januvia, Onglyza/Kombiglyze, Tradjenta, Nesina, Galvus, and Other Drugs)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138325
- Pages: 200
-
Format:
Report Overview
The APAC DPP- IV Inhibitors market size stood at around USD $3.7 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 9.4% during the forecast period
DPP-4 inhibitorsare important oral antidiabetic agents that are placed as second-line therapy after metformin failure as insulinotropic agents that have no intrinsic hypoglycaemia risk and are body weight neutral. Under hyperglycaemic conditions they additionally inhibit glucagon secretion
Market Drivers
Some of thefactors, which contribute to the increased prevalence of diabetes are urbanization and modernization, dietary factor, smoking, and environmental pollution
1. APAC DPP- IV Inhibitors Overview
A. Market Size
2. APAC DPP- IV Inhibitors Growth Drivers A. Increased prevalence of diabetes are urbanization and modernization, dietary factor, smoking, and environmental pollution
3. APAC DPP- IV Inhibitors Segmentation
A. By Drug
I. Januvia
II. Onglyza/Kombiglyze
III. Tradjenta
IV. Nesina
V. Galvus
VI. Other Drugs
4. APAC DPP- IV Inhibitors Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Merck, Company overview, Product & Services, Strategies & Financials
B. AstraZeneca, Company overview, Product & Services, Strategies & Financials
C. Novartis, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
